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peptides at one end only, the, results are not mechanically impressive. The hides of cattle suffering from a deficiency of the enzyme in the skin which cleaves the amino terminal peptides are so weak as to tear under their own weight, or on very slight trauma.
All stages of maturation of collagen fibrils occur in the presence of soluble polymer. In the early stages of tendon development collagen is laid down as thin, uniform fibrils, which in cross section are arrayed so regularly as to appear crystalline. At this. stage, the interfibrillar proteoglycan is rich in chondroitin sulphate. Somewhat later, the collagen fibrils begin to thicken rapidly, increasing in diameter by more than twentyfold at maturity. The sudden growth phase coincides with a sharp drop in the tissue concentration of chondroitin sulphate, and it appears that chondroitin sulphate proteoglycan has an inhibiting effect on fibril thickening (Scott et al. 1981) . Indeed, those tissues (cornea, cartilage territories) which retain a high chondroitin sulphate content into maturity tend to have fine, regular collagen fibrils. A second proteoglycan, the dermatan sulphate proteoglycan, present in lower concentrations than chondroitin sulphate proteoglycan during early development, remains as the major proteoglycan in mature tendon. Electronmicroscopy shows it to be associated with the collagen fibril in a very regular and specific way. It is placed where it would be expected to influence the occurrence of chemical cross-linking between adjacent fibrils (which stabilizes and strengthens maturing tissue), and also the possible nucleation of calcification as it occurs in some tendons, and possibly in bone.
Dermatan sulphate proteoglycan resembles, in many respects, heparan sulphate proteoglycan, which is intimately associated with some cell membranes. Both proteoglycans probably bind to their respective substrates (i.e. cell membranes and collagen fibrils) via their polypeptide cores.
By contrast, chondroitin sulphate proteoglycan appears to serve mainly a mechanical, spacefilling function, e.g. as the 'stuffing' which keeps the collagen fibrils apart, as in cartilage, cornea, young tendon, etc.
The highly effective and elegant structures which are laid down in youth normally stand up well for decades to the mechanical stresses of living. However, these structures are all extracellular, and hence not so accessible to repair. They are turned over relatively slowly -indeed, much of the mature collagen may not be turned over at all -and the tissue thus accumulates insults and petty damage. Destruction of collagen fibrils is therefore a serious event. They may be replaced, in the process of healing, but scar formation is usual -i.e. the repair is inferior to the original tissue, both in appearance and function.
The proteoglycans surrounding the fibrils serve as a protective barrier, which, as in the case of cartilage, may be very effective. Only after removal of the proteoglycan can the collagen fibril be enzymatically attacked and degraded, as happens in rheumatoid arthritis. Loss of proteoglycan seems not to be such a serious problem. The proteoglycan may be replaced, with some success in restoring structure and function. In this context, it should be noted that hyaluronate is particularly vulnerable to damage by radiation, and presumably by other free radical producing agents.
Ageing affects the function of connective tissue more obviously than almost any other organ or system. Collagen fibrils thicken, and the amounts of soluble polymer decrease. The connective tissue cells (? perhaps because their communications are thus severed) tend to decline in number and die off. Cartilages become less elastic, and their complement of proteoglycans changes both quantitatively and qualitatively. The interesting question is -how many of these processes are 'normal', that continue blindly and automatically, beyond the point at which they are useful? Does prevention of 'ageing' in connective tissues simply imply inhibitions of cross-linking in collagen fibrils and a slight stimulation of the production of chondroitin sulphate proteoglycan?
[For recent short reviews see Scott (1982) 
